Pretreatment with neem (Azadirachta indica) leaf preparation in Swiss mice diminishes leukopenia and enhances the antitumor activity of cyclophosphamide

Phytotherapy Research

Volumn 20, Issue 9, 2006, Pages 814-818

  Ghosh, Diptendu ^a   Bose, Anamika ^a   Haque, Enamul ^a   Baral, Rathindranath ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Cyclophosphamide; Cytotoxicity; Ehrlich's carcinoma; Leukopenia; Neem; Neutropenia

Indexed keywords

AZADIRACHTA INDICA EXTRACT; COLONY STIMULATING FACTOR; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; AZADIRACHTA INDICA; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; FEMALE; IMMUNOSTIMULATION; IN VITRO STUDY; LEUKOCYTE COUNT; LEUKOPENIA; NEUTROPENIA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLANT LEAF; SUSTAINED RELEASE PREPARATION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; AZADIRACHTA; CARCINOMA, EHRLICH TUMOR; CYCLOPHOSPHAMIDE; DRUG SYNERGISM; FEMALE; LEUKOCYTES, MONONUCLEAR; LEUKOPENIA; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES;

AZADIRACHTA INDICA;

EID: 33748797130     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1948     Document Type: Article

References (15)

1. Bain BJ. 1966. Basic hematological techniques. In Practical Hematology, 8th edn, Dacie JV, Lewis SM (eds). Churchill-Livingstone: Edinburgh, 49-82.
2. Baral RN, Chattopadhyay U. 2004. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma. Int Immunopharmacol 4: 355-366.
3. Baral RN, Mandai I, Chattopadhyay U. 2005. Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine. Int Immunopharmacol 5: 1343-1352.
4. Biswas K, Chattopadhyay I, Banerjee RK, Bandopadhyay U. 2002. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci 82: 1336-1345.
5. Bose A, Ghosh D, Pal S, Chaudhuri S, Baral RN. 2005. Neem leaf preparation enhances in vitro cytotoxic efficacy of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients. Indian J Med Res (Suppl) 121: 60.
6. Devereux S, Linch D. 1990. Hematopoietic growth factors. Q J Med 75: 537-550.
7. Hague E, Baral RN. 2005. Neem leaf mediated prophylactic growth inhibition of murine tumors: Possible immune mechanism involving macrophages and NK cells. Indian J Med Res (Suppl) 121: 80.
8. Hague E, Baral RN. 2006. Neem (Azadirachta indica) leaf preparation induces prophylactic growth inhibition of murine Ehrlich carcinoma in Swiss and C57BL/6 by activation of NK cells and NK-T cells. Immunobiology (in press).
9. Hague E, Mandai I, Pal S, Baral RN. 2006. Prophylactic dose of neem (Azadirachta indica) leaf preparation restricting murine tumor growth is nontoxic, hematostimulatory and immunostimulatory. Immunopharmacol Immunotoxicol 28: 33-50.
10. Johnson EM, Crawford J. 1998. Hemotopoietic growth factors in the reduction of chemotherapeutic toxicity. Semin Oncol 25: 552-561.
11. Marina NM, Shema SJ, Bowman LC et al. 1994. Failure of granulocyte macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin and etoposide chemotherapy. Med Pediatr Oncol 23: 328-334.
12. Noda I, Fujieda S, Ohtsubo T et al. 1999. Granulocyte colony-stimulating factor enhances invasive potential of human head-and-neck carcinoma cell lines. Int J Cancer 80: 78-84.
13. Pizzo PA. 1984. Granulocytopenia and cancer therapy. Past problems, current solutions and future challenges. Cancer 54: 2649-2666.
14. Stewart JA, Bear HD, Glass AG, Bornstein R. 1994. The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin- cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project. Am J Clin Oncol 17: 374-381.
15. Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR. 2004. Prophylactic granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. J Clin Oncol 22: 3350-3356.